Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo

Carlos Hermenegildo, Rosana Sáez, Claudio Minoia, Luigi Manzo, Vicente Felipo

Research output: Contribution to journalArticle

Abstract

Aluminium is neurotoxic and is considered a possible etiologic factor in Alzheimer's disease, dialysis syndrome and other neurological disorders. The molecular mechanism of aluminium-induced impairment of neurological functions remains unclear. We showed that aluminium impairs the glutamate-nitric oxide- cGMP pathway in cultured neurons. The aim of this work was to assess by in vivo brain microdialysis whether chronic administration of aluminium in the drinking water (2.5% aluminium sulfate) also impairs the glutamate-nitric oxide-cGMP pathway in the cerebellum of rats in vivo. Chronic exposure to aluminium reduced NMDA-induced increase of extracellular CGMP by ca 50%. The increase in extracellular CGMP induced by the nitric oxide generating agent S-nitroso-N-acetylpenicillamine was higher (240%) in rats treated with aluminium than in controls. Immunoblotting experiments showed that aluminium reduced the cerebellar content of calmodulin and nitric oxide synthase by 34 and 15%, respectively. Basal activity of soluble guanylate cyclase was decreased by 66% in aluminium-treated rats, while the activity after stimulation with S-nitroso-N-acetylpenicillamine was similar to controls. Basal cGMP in the cerebellar extracellular space was decreased by 50% in aluminium-treated rats. These results indicate that chronic exposure to aluminium reduces the basal activity of guanylate cyclase and impairs the glutamate-nitric oxide-cGMP pathway in the animal in vivo.

Original languageEnglish
Pages (from-to)245-253
Number of pages9
JournalNeurochemistry International
Volume34
Issue number3
DOIs
Publication statusPublished - Mar 1999

Fingerprint

Cyclic GMP
Aluminum
Glutamic Acid
Nitric Oxide
S-Nitroso-N-Acetylpenicillamine
Guanylate Cyclase
Microdialysis
Extracellular Space
N-Methylaspartate
Calmodulin
Nervous System Diseases
Immunoblotting
Nitric Oxide Synthase
Drinking Water
Cerebellum
Dialysis
Alzheimer Disease
Neurons

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo. / Hermenegildo, Carlos; Sáez, Rosana; Minoia, Claudio; Manzo, Luigi; Felipo, Vicente.

In: Neurochemistry International, Vol. 34, No. 3, 03.1999, p. 245-253.

Research output: Contribution to journalArticle

Hermenegildo, Carlos ; Sáez, Rosana ; Minoia, Claudio ; Manzo, Luigi ; Felipo, Vicente. / Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo. In: Neurochemistry International. 1999 ; Vol. 34, No. 3. pp. 245-253.
@article{7847e023155346e1ba42f01374d1252f,
title = "Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo",
abstract = "Aluminium is neurotoxic and is considered a possible etiologic factor in Alzheimer's disease, dialysis syndrome and other neurological disorders. The molecular mechanism of aluminium-induced impairment of neurological functions remains unclear. We showed that aluminium impairs the glutamate-nitric oxide- cGMP pathway in cultured neurons. The aim of this work was to assess by in vivo brain microdialysis whether chronic administration of aluminium in the drinking water (2.5{\%} aluminium sulfate) also impairs the glutamate-nitric oxide-cGMP pathway in the cerebellum of rats in vivo. Chronic exposure to aluminium reduced NMDA-induced increase of extracellular CGMP by ca 50{\%}. The increase in extracellular CGMP induced by the nitric oxide generating agent S-nitroso-N-acetylpenicillamine was higher (240{\%}) in rats treated with aluminium than in controls. Immunoblotting experiments showed that aluminium reduced the cerebellar content of calmodulin and nitric oxide synthase by 34 and 15{\%}, respectively. Basal activity of soluble guanylate cyclase was decreased by 66{\%} in aluminium-treated rats, while the activity after stimulation with S-nitroso-N-acetylpenicillamine was similar to controls. Basal cGMP in the cerebellar extracellular space was decreased by 50{\%} in aluminium-treated rats. These results indicate that chronic exposure to aluminium reduces the basal activity of guanylate cyclase and impairs the glutamate-nitric oxide-cGMP pathway in the animal in vivo.",
author = "Carlos Hermenegildo and Rosana S{\'a}ez and Claudio Minoia and Luigi Manzo and Vicente Felipo",
year = "1999",
month = "3",
doi = "10.1016/S0197-0186(99)00010-8",
language = "English",
volume = "34",
pages = "245--253",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo

AU - Hermenegildo, Carlos

AU - Sáez, Rosana

AU - Minoia, Claudio

AU - Manzo, Luigi

AU - Felipo, Vicente

PY - 1999/3

Y1 - 1999/3

N2 - Aluminium is neurotoxic and is considered a possible etiologic factor in Alzheimer's disease, dialysis syndrome and other neurological disorders. The molecular mechanism of aluminium-induced impairment of neurological functions remains unclear. We showed that aluminium impairs the glutamate-nitric oxide- cGMP pathway in cultured neurons. The aim of this work was to assess by in vivo brain microdialysis whether chronic administration of aluminium in the drinking water (2.5% aluminium sulfate) also impairs the glutamate-nitric oxide-cGMP pathway in the cerebellum of rats in vivo. Chronic exposure to aluminium reduced NMDA-induced increase of extracellular CGMP by ca 50%. The increase in extracellular CGMP induced by the nitric oxide generating agent S-nitroso-N-acetylpenicillamine was higher (240%) in rats treated with aluminium than in controls. Immunoblotting experiments showed that aluminium reduced the cerebellar content of calmodulin and nitric oxide synthase by 34 and 15%, respectively. Basal activity of soluble guanylate cyclase was decreased by 66% in aluminium-treated rats, while the activity after stimulation with S-nitroso-N-acetylpenicillamine was similar to controls. Basal cGMP in the cerebellar extracellular space was decreased by 50% in aluminium-treated rats. These results indicate that chronic exposure to aluminium reduces the basal activity of guanylate cyclase and impairs the glutamate-nitric oxide-cGMP pathway in the animal in vivo.

AB - Aluminium is neurotoxic and is considered a possible etiologic factor in Alzheimer's disease, dialysis syndrome and other neurological disorders. The molecular mechanism of aluminium-induced impairment of neurological functions remains unclear. We showed that aluminium impairs the glutamate-nitric oxide- cGMP pathway in cultured neurons. The aim of this work was to assess by in vivo brain microdialysis whether chronic administration of aluminium in the drinking water (2.5% aluminium sulfate) also impairs the glutamate-nitric oxide-cGMP pathway in the cerebellum of rats in vivo. Chronic exposure to aluminium reduced NMDA-induced increase of extracellular CGMP by ca 50%. The increase in extracellular CGMP induced by the nitric oxide generating agent S-nitroso-N-acetylpenicillamine was higher (240%) in rats treated with aluminium than in controls. Immunoblotting experiments showed that aluminium reduced the cerebellar content of calmodulin and nitric oxide synthase by 34 and 15%, respectively. Basal activity of soluble guanylate cyclase was decreased by 66% in aluminium-treated rats, while the activity after stimulation with S-nitroso-N-acetylpenicillamine was similar to controls. Basal cGMP in the cerebellar extracellular space was decreased by 50% in aluminium-treated rats. These results indicate that chronic exposure to aluminium reduces the basal activity of guanylate cyclase and impairs the glutamate-nitric oxide-cGMP pathway in the animal in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0345279851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345279851&partnerID=8YFLogxK

U2 - 10.1016/S0197-0186(99)00010-8

DO - 10.1016/S0197-0186(99)00010-8

M3 - Article

C2 - 10355491

AN - SCOPUS:0345279851

VL - 34

SP - 245

EP - 253

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 3

ER -